• Mashup Score: 1
    ESC 23: ARAMIS: Anakinra versus Placebo in Acute Myocarditis - 8 month(s) ago

    ESC 23 – We are joined onsite by Dr Mathieu Kerneis (Pitie Salpetriere APHP University Hospital, FR) and Dr Gilles Montalescot to discuss the findings from the ARAMIS trial. ARAMIS was the

    Source: www.ecrjournal.com
    Categories: Latest Headlines, Partners & KOLs
    Tweet Tweets with this article
    • Profile photo of radcliffeCARDIO
      radcliffeCARDIO

      🫀NEW #ESCCongress #LBCT Interview 💫Dr @mathieukerneis and Dr Gilles Montalescot discuss findings from the #ARAMIS trial. 📽️👉 https://t.co/zg9bByyrEO 📊Results showed that #anakinra was safe but did not reduce the complications of acute myocarditis. #ESC2023 #CardioTwitter https://t.co/9AGMF59hbX

  • Mashup Score: 0
    COVID-19 Guideline, Part 1: Treatment and Management - 11 month(s) ago

    IDSA has developed living, frequently updated evidence-based guidelines to support patients, clinicians and other health-care professionals in their decisions about treatment and management of patients with COVID-19 infection. Summarized here are the recommendations with comments related to the clinical practice guideline for the treatment and management of COVID-19.

    Source: www.idsociety.org
    Categories: Infectious Disease, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of IDSAInfo
      IDSAInfo

      ICYMI, IDSA has released a new recommendation on #anakinra and updated remarks for the existing recommendation on the use of #nirmatrelvir/#ritonavir in the treatment of patients with COVID-19 📝: https://t.co/InyRvQiYjp #IDSAGuidelines #COVID19Guidelines

  • Mashup Score: 7
    COVID-19 Guideline, Part 1: Treatment and Management - 11 month(s) ago

    IDSA has developed living, frequently updated evidence-based guidelines to support patients, clinicians and other health-care professionals in their decisions about treatment and management of patients with COVID-19 infection. Summarized here are the recommendations with comments related to the clinical practice guideline for the treatment and management of COVID-19.

    Source: www.idsociety.org
    Categories: Infectious Disease, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of IDSAInfo
      IDSAInfo

      IDSA has released a new recommendation on #anakinra and updated remarks for the existing recommendation on the use of #nirmatrelvir/#ritonavir in the treatment of patients with COVID-19. 📝: https://t.co/InyRvQiYjp #IDSAGuidelines #COVID19Guidelines https://t.co/hxn2g9ZoOz

  • Mashup Score: 6
    Efficacy and safety of emapalumab in macrophage activation syndrome - 1 year(s) ago

    Objectives Macrophage activation syndrome (MAS) is a severe, life-threatening complication of systemic juvenile idiopathic arthritis (sJIA) and adult-onset Still’s disease (AOSD). The objective of this study was to confirm the adequacy of an emapalumab dosing regimen in relation to interferon-γ (IFNγ) activity by assessing efficacy and safety. The efficacy outcome was MAS remission by week 8,…

    Source: Annals of the Rheumatic Diseases
    Categories: Latest Headlines, Rheumatology
    Tweet Tweets with this article
    • Profile photo of ARD_BMJ
      ARD_BMJ

      ⚠️ #MAS is a life-threatening complication of #sJIA & #AOSD 🔥 ⚗️ #emapalumab -anti-IFNγ- was administered to 14 pts who had previously failed high-dose #glucocorticoids, with or without #anakinra and/or #ciclosporin 📉 remission in 13/14 pts 👉 Link: https://t.co/L96b8wdXjX https://t.co/kv2K1DwPAh

  • Mashup Score: 0
    Prednisone bests anakinra, zinc for 90-day survival in severe alcohol-related hepatitis - 1 year(s) ago

    WASHINGTON — Prednisone induced a higher 90-day survival rate and lower incidence of acute kidney injury compared with anakinra and zinc sulfate in patients with severe alcohol-associated hepatitis, according to late-breaking data. “Alcohol-associated hepatitis (AH) is an acute clinical syndrome resulting from heavy and sustained alcohol consumption. Severe AH has a 90-day mortality

    Source: www.healio.com
    Categories: Gastroenterology, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of HealioGastro
      HealioGastro

      #Prednisone bests #anakinra, #zinc for 90-day survival in severe alcohol-related #hepatitis #TLM2022 #LiverMtg22 #LiverTwitter https://t.co/CfCm5JSpWr

  • Mashup Score: 0
    Anakinra in Patients With Systemic Juvenile Idiopathic Arthritis: Long-term Safety From the Pharmachild Registry - 2 year(s) ago

    Objective To evaluate the long-term safety profile of anakinra in patients with systemic juvenile idiopathic arthritis (sJIA). Methods Data from patients with sJIA enrolled in the Pharmachild registry ([ClinicalTrials.gov][1]: [NCT03932344][2]) prior to September 30, 2018, and treated with anakinra were analyzed. The study endpoints were the occurrence of non-serious adverse events (SAEs) of at…

    Source: The Journal of Rheumatology
    Categories: Latest Headlines, Rheumatology
    Tweet Tweets with this article
    • Profile photo of jrheum
      jrheum

      Video Abstract Anakinra in Patients With Systemic Juvenile Idiopathic Arthritis: Long-term Safety From the Pharmachild Registry #anakinra #juvenileidiopathicarthritis Read the full article: 📰 https://t.co/DyjblBDcSg Watch the video 📺 https://t.co/xP3e0aBlaU

  • Mashup Score: 0
    Anakinra in Patients With Systemic Juvenile Idiopathic Arthritis: Long-term Safety From the Pharmachild Registry - 2 year(s) ago

    Objective To evaluate the long-term safety profile of anakinra in patients with systemic juvenile idiopathic arthritis (sJIA). Methods Data from patients with sJIA enrolled in the Pharmachild registry ([ClinicalTrials.gov][1]: [NCT03932344][2]) prior to September 30, 2018, and treated with anakinra were analyzed. The study endpoints were the occurrence of non-serious adverse events (SAEs) of at…

    Source: The Journal of Rheumatology
    Categories: Latest Headlines, Rheumatology
    Tweet Tweets with this article
    • Profile photo of jrheum
      jrheum

      Open Access Anakinra in Patients With Systemic Juvenile Idiopathic Arthritis: Long-term Safety From the Pharmachild Registry 📰 https://t.co/DyjblBDcSg #anakinra #adverseeffects #juvenileidiopathicarthritis https://t.co/8qDKSlhpuW

  • Mashup Score: 4
    ShortURL - URL Shortener - 2 year(s) ago

    ShortURL is a url shortener to reduce a long link. Use our tool to shorten links and then share them, in addition you can monitor traffic statistics.

    Source: www.shorturl.at
    Categories: Cardiologists, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of GiuseppeGalati_
      GiuseppeGalati_

      Targetting the inflammasome in #cardiovascular diseases 🧩 Will be this a future treatment for #HeartFailure ? 🧩 What therapy : #anakinra #canakinumab #colchicine or other? @JACCJournals @DrMarthaGulati @JJheart_doc @DrNasrien @JavedButler1 @DLBHATTMD https://t.co/Gy2QZ2IDne https://t.co/EmkiOO8l79

Load More